Journal of the American Academy of Child & Adolescent Psychiatry
Letter to the EditorFamily Characteristics, Expressed Emotion, and Attention-Deficit/Hyperactivity Disorder
References (6)
- et al.
Changes in family function and relationships in children who respond to methylphenidate
J Am Acad Child Adolesc Psychiatry
(1987) - et al.
Disentangling child and family influences on maternal expressed emotion toward children with attention-deficit/hyperactivity disorder
J Am Acad Child Adolesc Psychiatry
(2011) - et al.
Mothers' expressed emotion toward their school-aged sons: associations with child and maternal symptoms of psychopathology
Eur Child Adolesc Psychiatry
(2007)
Cited by (6)
A follow-up study of maternal expressed emotion toward children with attention-deficit/hyperactivity disorder (ADHD): Relation with severity and persistence of adhd and comorbidity
2014, Journal of the American Academy of Child and Adolescent PsychiatryNew Insights on the Effects of Methylphenidate in Attention Deficit Hyperactivity Disorder
2020, Frontiers in PsychiatryExamining the Relationship Between Children’s ADHD Symptomatology and Inadequate Parenting: The Role of Household Chaos
2019, Journal of Attention DisordersParent Emotion Expression and Autonomic-Linked Emotion Dysregulation in Childhood ADHD
2018, Journal of Psychopathology and Behavioral AssessmentExternalizing Outcomes of Youth with and without ADHD: Time-Varying Prediction by Parental ADHD and Mediated Effects
2017, Journal of Abnormal Child PsychologyAttention-deficit/hyperactivity disorder developmental trajectories related to parental expressed emotion
2016, Journal of Abnormal Psychology
Disclosure: Dr. Sonuga-Barke has received speaker fees from Janssen-Cilag, Medice, and QBTech and has received consultancy, grant funding, advisory board fees, and conference support from Shire. Dr. Daley has served as a speaker or advisor or has received funding or travel support from Eli Lilly and Co., Janssen-Cilag, USB, and Shire. Dr. Thompson has received education sponsorship from Eli Lilly and Co., Janssen-Cilag, and Shire; unrestricted research grants from Eli Lilly and Co., Janssen-Cilag, UCB, and Shire; student funding from Eli Lilly and Co. and Janssen-Cilag; has served on the boards of Eli Lilly and Co. and Shire; and has received lecture fees from Eli Lilly and Co. and Janssen-Cilag. Drs. Cartwright, Brown, Bitsakou, Gramzow, Psychogiou, and Simonoff report no biomedical financial interests or potential conflicts of interest.